licensing agreement
Universal DX Closes $70M Series B Round, Inks Deal With Quest to Provide Colorectal Cancer Test
Under the agreement, Quest, an investor in the round, will have exclusive rights to provide Universal's Signal-C colorectal cancer screening test in the US.
Verici DX, Thermo Fisher Scientific Reach Licensing Deal for Pre-Transplant Prognostic Testing
Verici DX grants Thermo Fisher a worldwide exclusive license to develop and commercialize an assay for pre-transplant risk assessment of early kidney rejection.
23andMe, GSK Ink $20M Expanded Collaboration to Broaden Access to Genetic Database
The deal opens a new chapter in the relationship between the two firms, which saw an exclusive, five-year drug discovery collaboration expire in July.
Agilent Licenses Roswell Park-Developed Blood Cancer Test
The assay is intended to aid oncologists in diagnosing and directing appropriate treatment for patients with a variety of hematologic cancers.
Watchmaker Genomics Partners With Exact Sciences to Bring Epigenetic Analysis Technology to Market
Premium
Under the co-exclusive agreement, Watchmaker will gain access to Exact's bisulfite-free DNA methylation analysis technology, called TAPS.